Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele announced Orchard was granted an exclusive worldwide license to intellectual property rights to research, develop, manufacture and commercialize the ex vivo autologous hematopoietic stem cell (HSC)...